DRDO Chairman Satheesh Reddy on 2-DG drug for treatment of Covid patients - TV9 Exclusive
DRDO chief G. Satheesh Reddy said that 2-DG drug, the anti-COVID drug, which has been approved for emergency use, will be possibly rolled out by either May 11 or 12th. In an exclusive conversation with TV9 media, the DRDO chief said that the drug 2-deoxy-D-glucose (2-DG) had been developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRDO), in collaboration with Dr Reddy’s Laboratories (DRL), Hyderabad.
He said the drug would be available in a powder form like glucose. DRDO Chairman said the drug had been approved by the Drugs Controller General of India (DCGI) for emergency use. He said the drug would help improve the level of oxygen in the body.
Watch the full video for more insight.